Bifunctional Perfluoroaryl Boranes
Organometallics, Vol. 25, No. 2, 2006 357
(CD2Cl2): δ 2.65 (s, 3H, MeCN). 19F NMR (CD2Cl2): δ -124.5
(2F, C12F8), -130.7 (1F, C6F4), -131.4 (2F, C12F8), -131.8 (2F,
C12F8), -132.6 (1F, C6F4), -133.5 (2F, C12F8), -142.2 (2F, C12F8),
-153.5 (4F, 2 overlapping signals, C12F8), -155.1 (2F, C12F8),
-155.3 (1F, C6F4), -158.0 (1F, C6F4). 11B{1H} (CD2Cl2): 49.2
(br), -5.6 (br). X-ray quality crystals of 2‚MeCN were obtained
by layering hexanes onto a CH2Cl2 solution of 2‚MeCN and cooling
to -40 °C.
Synthesis of C6F4-1,2-[B(C12F8)2]‚THF (2‚THF). In the glove-
box, C6F4-1,2-[B(C12F8)]2, 2 (0.100 g, 0.13 mmol), was weighed
into a vial and dissolved in CH2Cl2 (8 mL). THF (0.010 g, 0.14
mmol) was also weighed into a vial and diluted with CH2Cl2 (2
mL). The solutions were combined, stirred for 10 min, and place
in the freezer (-40 °C) overnight. The solution was decanted, and
the solid product was dried in vacuo (0.103 g, 94%). 1H NMR (CD2-
Cl2): δ 4.24 (m, 4H, THF)), 2.13 (m, 4H, THF). 19F NMR (CD2-
Cl2): δ -124.6 (2F, C12F8), -130.7 (2F, C12F8), -131.5 (2F,
C12F8), -132.2 (3F, 2 overlapping signals, C12F8 and C6F4), -132.5
(1F, C6F4), -142.2 (2F, C12F8), -152.4 (2F, C12F8), -153.5 (2F,
C12F8), -154.2 (2F, C12F8), -154.9 (1F, C6F4), -157.2 (1F, C6F4).
11B{1H} NMR (CD2Cl2): δ 39.9, 6.3. X-ray quality crystals of
2‚THF were obtained by layering hexanes onto a CH2Cl2 solution
of 2‚THF and cooling to -40 °C. X-ray quality crystals of
2‚(THF)2 were obtained by layering excess equivalents of THF
(1.0 mL, 0.05 M solution in hexanes, 0.062 mmol) over a solution
of 2 (10 mg, 0.013 mmol) in CH2Cl2 (0.3 mL), which was allowed
to stand at -40 °C.
(1F, C6F4), -133.5 (2F, C12F8), -142.2 (2F, C12F8), -153.5 (4F,
2 overlapping signals, C12F8), -155.1 (2F, C12F8), -155.3 (1F,
C6F4), -158.0 (1F, C6F4). 11B{1H} (CD2Cl2): 49.2 (br), -5.6 (br).
2 + 2.0 equiv MeCN (2‚(MeCN)2): 1H NMR (CD2Cl2, 301 K):
2.40 (s, 3H, MeCN). 19F NMR (CD2Cl2, 301 K): -128.0 (4F,
C12F8), -131.6 (2F, C6F4), -132.6 (4F, C12F8), -147.9 (4F, C12F8),
-154.3 (4F, C12F8), -156.7 (2F, C6F4).
2 + 0.9 equiv THF. 1H NMR (CD2Cl2, 301 K): δ 3.77 (m, 4H,
THF), 1.87 (m, 4H, THF). 19F NMR (CD2Cl2, 301 K): δ -126.5
(4F, C12F8), -131.9 (4F, C12F8), -132.3 (2F, C6F4), -147.5 (4F,
1
C12F8), -153.9 (4F, C12F8), -156.1 (2F, C6F4). H NMR (CD2-
Cl2, 193 K): δ 3.62 (br, 4H, THF), 1.76 (br, 4H, THF). 19F NMR
(CD2Cl2, 193 K): δ -131.2 (2F, C6F4), -131.5 (4F, C12F8), -134.2
(4F, C12F8), -154.8 (4F, C12F8), -155.2 (4F, C12F8), -158.3 (2F,
C6F4). 11B {1H} NMR: 39.9 (br s), 6.3 (br s). 2 + 2.0 equiv THF
(2‚(THF)2): 1H NMR (CD2Cl2, 301 K): δ 3.94 (m, 4H, THF),
-1.97 (m, 4H, THF). 19F NMR (CD2Cl2, 301 K): -126.4 (4F,
C12F8), -131.9 (4F, C12F8), -132.3 (2F, C6F4), -147.4 (4F, C12F8),
-153.9 (4F, C12F8), -156.1 (2F, C6F4).
X-ray Crystallography. Measurements were made on either a
Nonius Kappa CCD or Bruker SMART 1K CCD diffractometer
using graphite-monochromated Mo KR radiation (0.71073 Å). The
structures were solved by direct methods and refined on F2 values
by full-matrix least squares for all unique data. Table 3 gives further
details, and the crystallographic information files are available as
Supporting Information. The CCDC contains the supplementary
crystallographic data for the crystal structures reported in this paper
(CCDC 278193, [K]+2[C6F5-1,2-(BF3)2]2-; CCDC 278389, [K]+-
{C6F4-1,2-[(BF2)2(µ-F)]}-; CCDC 278192, 2; CCDC 279195,
1‚MeCN; CCDC 281017, 2‚MeCN; CCDC 278194, 1‚(MeCN)2;
CCDC 278196, 2‚(THF)2; CCDC 278197, 2‚THF, Supporting
Information only). These data can be obtained, free of charge, via
Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, U.K. (fax: 44-1223-336033 or e-mail: deposit@
ccdc.cam.ac.uk)).
Spectroscopic Studies of the Addition of LB to 1 and 2. In a
glovebox a 5 mm NMR tube was charged with a known amount
of 1 or 2 (∼0.012 mmol), and CD2Cl2 (0.4 mL) was added. The
sample was capped with a rubber septum and removed from the
glovebox. Varying equivalents of dry and degassed LB (LB )
MeCN, 0.464 M in CD2Cl2; LB ) THF, 0.500 M in CD2Cl2) was
added via gastight syringe, and the NMR tube was placed in the
spectrometer.
1
1 + 1.0 MeCN. H NMR (CD2Cl2, 298 K): δ 2.51 (s, 3H,
MeCN). 19F NMR (CD2Cl2, 298 K): δ -127.5 (10F, -C6F4 and
o-B(C6F5)2), -143.2 (br, 4F, o-B(C6F5)2), -148.7 (br, 2F, -C6F4),
-161.0 (8F, m-B(C6F5)2). 11B{1H} NMR (CD2Cl2. 228 K): δ 41.7,
-8.6. 1 + 2.0 MeCN (1‚(MeCN)2): 1H NMR (CD2Cl2, 298 K):
δ 2.27 (s, 3H, MeCN). 19F NMR (CD2Cl2, 298 K): δ -128.2 (2F,
-C6F4), -130.6 (8F, o-B(C6F5)2), -151.0 (4F, p-B(C6F5)2), -157.1
(2F, -C6F4), -162.3 (8F, m-B(C6F5)2). 1 + 3.0 MeCN: 1H NMR
(CD2Cl2, 298 K): δ 2.15 (s, 3H, MeCN). 19F NMR (CD2Cl2, 298
K): δ -127.8 (2F, -C6F4), -130.9 (8F, o-B(C6F5)2), -152.0 (4F,
p-B(C6F5)2), -157.6 (2F, -C6F4), -162.5 (8F, m-B(C6F5)2). 11B-
{1H} NMR (CD2Cl2): δ -7.0.
Acknowledgment. Funding for this work came from the
Natural Sciences and Engineering Research Council of Canada
in the form of a Discovery Grant (to W.E.P.) and Postgraduate
Fellowship support (to P.A.C. and L.D.H.). W.C. acknowledges
the EPSRC (UK) for equipment funding.
Supporting Information Available: Crystallographic informa-
tion files for [K]2+[C6F4-1,2-(BF3)2]2-, [K]+{C6F4-1,2-[(BF2)2-
(µ-F)]}-, 2, 1‚MeCN, 2‚MeCN, 2‚THF, 1‚(MeCN)2, and 2‚(THF)2,
as well as ORTEP diagrams for each structure and selected 19F
NMR spectra. This material is available free of charge via the
1
2 + 0.8 equiv MeCN. H NMR (CD2Cl2, 301 K): δ 2.65 (s,
3H, MeCN). 19F NMR (CD2Cl2, 301 K): δ -124.5 (2F, C12F8),
-130.7 (1F, C6F4), -131.4 (2F, C12F8), -131.8 (2F, C12F8), -132.6
OM050764T